| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 211 |
| 1 | DUPILUMAB | 5 |
| 2 | IBUPROFEN | 5 |
| 3 | INFLIXIMAB | 4 |
| 4 | RISANKIZUMAB-RZAA | 4 |
| 5 | ADALIMUMAB | 3 |
| 6 | ALBUTEROL SULFATE | 3 |
| 7 | COPPER | 3 |
| 8 | ETONOGESTREL AND ETHINYL ESTRADIOL | 3 |
| 9 | UPADACITINIB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ECALLANTIDE | 2 | 0.0011 |
| 1 | LEVONORGESTREL | 211 | 0.0010 |
| 2 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 3 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 4 | PRASTERONE | 1 | 0.0004 |
| 5 | CEFIXIME | 1 | 0.0003 |
| 6 | NORGESTIMATE AND ETHINYL ESTRADIOL | 1 | 0.0002 |
| 7 | IMIGLUCERASE | 1 | 0.0002 |
| 8 | ICATIBANT ACETATE | 1 | 0.0002 |
| 9 | LORATADINE PSEUDOEPHEDRINE SULFATE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 1 | Progestin [EPC] | 215 | 0.0007 |
| 2 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 5 | Copper-containing Intrauterine Device [EPC] | 3 | 0.0001 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 7 | Interleukin-23 Antagonist [EPC] | 4 | 0.0000 |
| 8 | Janus Kinase Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Complement Inhibitor [EPC] | 1 | 0.0000 |